<DOC>
	<DOCNO>NCT02493543</DOCNO>
	<brief_summary>The purpose study determine autoantibody profile spinal cord injury role spontaneous functional recovery .</brief_summary>
	<brief_title>Autoantibodies Spinal Cord Injury</brief_title>
	<detailed_description>Most patient experience variable degree functional recovery spinal cord injury ( SCI ) , predominantly first month lesion . In SCI animal model , autoantibody pathogenic titer rise time spontaneous recovery stop . The aim study determine autoantibody profile SCI infer relation functional recovery . To achieve , autoantibody profile determine serum blood sample functional recovery evaluate accordingly standardized scale .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>Traumatic nonprogressive vascular SCI Less 45 day lesion Any neurological level Complete incomplete lesion If patient treat glucocorticoid , pass least 7 day end treatment Cauda equina syndrome Autoimmune disorder Tumor ( even benign ) Neurodegenerative disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>autoantibody</keyword>
</DOC>